reports
Balchem Corporation Reports Fourth Quarter and Full Year 2025 Financia...
Balchem Corporation Reports Fourth Quarter and Full Year 2025 Financial Results MONTVALE, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal fourth quarter and full year ended December 31, 2025. For the quarter, the Company reported net sales of $263.6 million, net earnings of $39.2 million, adjusted EBITDA(a) of $67.9 million, and free cash flow(a) of $51.2 million. For the full year 2025, the Company reported net sales of $1.037 billion, net earnings of $154.8 million, adjusted EBITDA of $274.9 million, and fre...
Fennec Pharmaceuticals Presents Real World Data Supporting the Integra...
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers – Administration of PEDMARK® Approximately Six Hours After Cisplatin was Shown to Be Safe & Easily Integrated into Care for Adults with Head & Neck Cancers (HNC) – – Early Signals of Hearing Preservation Highlight the Potential of PEDMARK® to Address Cisplatin-Induced Hearing Loss, a Critical Survivorship Gap, Without Compromising Cisplatin’s Established Antitumor Activity – – Majority of High-Risk Patients Receiving PEDMARK® Demonstrated No M...
Novo Nordisk A/S: Notice for the Annual General Meeting of Novo Nordis...
Novo Nordisk A/S: Notice for the Annual General Meeting of Novo Nordisk A/S Bagsværd, Denmark, 20 February 2026 – The Annual General Meeting will be held on: Thursday 26 March 2026 at 14:00 (CET) The Annual General Meeting will be held as a combined physical and virtual meeting. Accordingly, shareholders can choose between participating in person at Bella Center, Center Boulevard 5, entrance 6, 2300 Copenhagen S, Denmark, or virtually by PC or smartphone/tablet. We encourage shareholders to exercise their rights by submitting proxies or votes by correspondence in advance of the Annual Gen...
Aquestive Therapeutics to Present New Clinical Data on Anaphylm™ (dibu...
Aquestive Therapeutics to Present New Clinical Data on Anaphylm™ (dibutepinephrine) Sublingual Film at the 2026 AAAAI Annual Meeting Anaphylm™ (dibutepinephrine) sublingual film achieved clinically relevant epinephrine plasma concentrations without diastolic blood pressure dip WARREN, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that multiple poster prese...
EVgo to Report Fourth Quarter and Full Year 2025 Results on March 3
EVgo to Report Fourth Quarter and Full Year 2025 Results on March 3 LOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- EVgo Inc. (Nasdaq: EVGO), one of the nation’s largest providers of public fast charging infrastructure for electric vehicles (EVs), today announced that it will release its fourth quarter and full year 2025 financial results on Tuesday, March 3. This release will be followed by a webcast hosted by members of the EVgo management team at 8 a.m. ET (5 a.m. PT). EVgo Fourth Quarter and Full Year 2025 WebcastWhen: Tuesday, March 3Time: 8 a.m. ET (5 a.m. PT)Live Webcast: A copy ...
Onex Reports Fourth Quarter and Full Year 2025 Results
Onex Reports Fourth Quarter and Full Year 2025 Results Convex generates record annual results including $711 million in net income All amounts in U.S. dollars unless otherwise stated TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Onex Corporation (TSX: ONEX) today announced its financial results for the fourth quarter and year ended December 31, 2025. Onex also released supplemental financial information for Convex Group Limited (“Convex”) for fiscal 2025. “The acquisition of Convex and partnership with AIG is a pivotal moment in Onex’ evolution that meaningfully enhances our growth prosp...
Bitdeer Announces Pricing of Upsized US$325.0 Million Convertible Seni...
Bitdeer Announces Pricing of Upsized US$325.0 Million Convertible Senior Notes Offering SINGAPORE, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (Nasdaq: BTDR) (“Bitdeer”), a world-leading technology company for Bitcoin mining and AI infrastructure, today announced the pricing of US$325.0 million principal amount of 5.00% Convertible Senior Notes due 2032 (the “notes”) in a private placement (the “notes offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The...
Bitdeer Announces Pricing of Registered Direct Offering of 5,503,030 C...
Bitdeer Announces Pricing of Registered Direct Offering of 5,503,030 Class A Ordinary Shares SINGAPORE, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (Nasdaq: BTDR) (“Bitdeer”), a world-leading technology company for Bitcoin mining and AI infrastructure, today announced the pricing of its registered direct offering of 5,503,030 of its Class A ordinary shares, par value US$0.0000001 per share (the “Class A ordinary shares”), to certain holders of its 5.25% convertible senior notes due 2029 (the “November 2029 notes”) at a price of US$7.94 per Class A ordinary share in a dire...
Telix to Participate in Oppenheimer and TD Cowen Conferences
Telix to Participate in Oppenheimer and TD Cowen Conferences MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will participate in the upcoming Oppenheimer 36th Annual Healthcare Life Sciences Conference (virtual) and in the TD Cowen 46th Annual Health Care Conference in Boston, MA (U.S.). Managing Director and Group CEO, Dr. Christian Behrenbruch, will take part in a fireside chat with Oppenheimer on Thursday, February 26, 2026 at 4:40 p.m. EST (Friday, Feb 27 at 8:40 a.m. AEDT). Kevin Richardson, Chi...
OTC Markets Group Welcomes Chemtrade Logistics Income Fund to OTCQX
OTC Markets Group Welcomes Chemtrade Logistics Income Fund to OTCQX NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced that (TSX: CHE.UN; OTCQX: CGIFF), a diversified operator and producer of industrial chemicals and services, has qualified to trade on the OTCQX® Best Market. Chemtrade Logistics Income Fund upgraded to OTCQX from the Pink Limited™ Market. Chemtrade Logistics Income Fund begins trading today on OTCQX under the symbol “CGIFF.” U.S. investors can find current financ...
Legence Sets Fourth Quarter and Full-Year 2025 Earnings Release Date a...
Legence Sets Fourth Quarter and Full-Year 2025 Earnings Release Date and Webcast Schedule SAN JOSE, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced that it will release results for the fourth quarter and full-year ended December 31, 2025 on Friday, March 27, 2026, prior to the market open. In conjunction with the release, the Company will host an earnings conference call and webcast to review the results and its operations on Friday, March 27, 2026, at 10:00 am EST. The call will be broadcast live in listen-only mode. T...
OTC Markets Group Welcomes IEH Corporation to OTCQX
OTC Markets Group Welcomes IEH Corporation to OTCQX NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (OTCQX: IEHC), a producer of high-performance PCB connectors, has qualified to trade on the OTCQX® Best Market. IEH Corporation upgraded to OTCQX from the OTCID™ Basic Market. IEH Corporation begins trading today on OTCQX under the symbol “IEHC.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . Trading on the OTCQX Market of...
AtaiBeckley To Host Virtual Investor Day on March 6, 2026
AtaiBeckley To Host Virtual Investor Day on March 6, 2026 NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced that it will host a Virtual Investor Day on Friday, March 6, 2026, from 9:00 a.m. to 12:00 p.m. ET. The event will feature presentations and live Q&A sessions with members of the Company’s executive leadership team and several external key opinion leaders....
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare...
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference POMPANO BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care, today announced that Company management will present at the 46th Annual TD Cowen Healthcare Conference being held in Boston, MA. 46th Annual TD Cowen Healthcare Conference: Format: PresentationDate: Monday, March 2, 2026Time: 3:50 pm ET Interested parties may access live and archived we...
nVent Adds Mellinda Devese as Chief Supply Chain Officer
nVent Adds Mellinda Devese as Chief Supply Chain Officer Integrated supply chain leader will drive growth, transformation, and operational excellence LONDON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- nVent Electric plc (NYSE: NVT) ("nVent"), a global leader in electrical connection and protection solutions, today announced the hiring of Mellinda Devese as Executive Vice President and Chief Supply Chain Officer, effective March 16, 2026. Devese will report directly to nVent Chair and CEO Beth Wozniak and lead nVent’s global, end-to-end integrated supply chain including manufacturing operations, ...
Mesoblast Financial Results and Corporate Update Webcast
Mesoblast Financial Results and Corporate Update Webcast NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the half year ended December 31, 2025. The webcast will begin at 5.00pm EST, Thursday, February 26; 9.00am AEDT, Friday, February 27, 2026. It can be accessed via: The archived webcast will be available on the Investor page of the Company’s website: About Mesoblast Mesoblast (the Company) is ...
Saltware Co Ltd: 1 director
A director at Saltware Co Ltd bought 40,692 shares at 811.000KRW and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
FLECT Co Ltd: 1 director
A director at FLECT Co Ltd sold 765,700 shares at 1,567.000JPY and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
- Filipe Botelho
- Josseline Jenssen
- Lorena Reich
FRO – Invitation to Q4 2025 Results Conference Call and Webcast
FRO – Invitation to Q4 2025 Results Conference Call and Webcast Frontline plc.’s preliminary fourth quarter 2025 results will be released on Friday February 27, 2026, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at ahead of the conference call. In order to attend the conference call you may do one of the following: a. WebcastGo to the Investor Relations section at and follow the “Webcast” link, or access directly from the link below. b. Confere...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.